Literature DB >> 4734261

Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.

G L Logue, W F Rosse, J P Gockerman.   

Abstract

The amount of the third component of complement (C3) bound to red cells of patients with the cold agglutinin syndrome was determined by a quantitative assay, measuring the fixation of the first component of complement by anti-C3. Abrupt reduction in the serum concentration of cold agglutinin by plasmapheresis markedly decreased the hemolytic rate, but the amount of C3 bound to circulating cells did not change appreciably. When this patient was transfused with normal cells. C3 accumulated on the transfused cells within 48 h to the level present on his own cells, but selective destruction of the transfused cells did not occur. When patients were subjected to acute cold stress, cell-bound C3 rose abruptly and intravascular hemolysis occurred. These studies suggest that most of the C3 detected on the circulating red cells of cold agglutinin patients is in an inactive form, and that the rate of attachment of C3 to the membrane is important in determining hemolysis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4734261      PMCID: PMC302279          DOI: 10.1172/JCI107206

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

Review 3.  The role of complement in antibody-mediated red-cell destruction.

Authors:  P L Mollison
Journal:  Br J Haematol       Date:  1970-03       Impact factor: 6.998

4.  Detection of bound C3 by a new immunochemical methods.

Authors:  T Borsos; E J Leonard
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

5.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

6.  C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

7.  Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

8.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

9.  Fixation of the first component of complement (C'la) by human antibodies.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  14 in total

1.  A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.

Authors:  Kathryn R Girard-Pierce; Sean R Stowell; Nicole H Smith; C Maridith Arthur; Harold C Sullivan; Jeanne E Hendrickson; James C Zimring
Journal:  Blood       Date:  2013-07-22       Impact factor: 22.113

2.  Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes.

Authors:  G L Logue; H J Cohen
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse; G L Logue; J Adams; J H Crookston
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

4.  Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.

Authors:  R H Dixon; W F Rosse
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

Review 5.  The role of complement in immune clearance of blood cells.

Authors:  U E Nydegger; M D Kazatchkine
Journal:  Springer Semin Immunopathol       Date:  1983

6.  [Immunopharmacology of corticosteroids].

Authors:  L H Block; W Vetter; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1982-11-15

7.  Quantitation of C3 subcomponents on red cells coated with complement in vitro.

Authors:  J Freedman; A Massey
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

8.  The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.

Authors:  C J Jaffe; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Sequestration of neuraminidase-treated erythrocytes. Studies on its topographic, morphologic and immunologic aspects.

Authors:  J M Janicik; R Schauer; K H Andres; M von Düring
Journal:  Cell Tissue Res       Date:  1978-01-17       Impact factor: 5.249

10.  Effect of corticosteroids on the human monocyte IgG and complement receptors.

Authors:  A D Schreiber; J Parsons; P McDermott; R A Cooper
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.